Skip to main content
SpringerLink
Log in
Book cover

Therapie des Endometriumkarzinoms pp 65–75Cite as

EGF Receptor (EGF-R) Analysis in Endometrial Carcinomas

  • Chapter

Abstract

A better understanding of cell growth and differentiation began with the detection of the proto-oncogenes [1]. In the process of tumor development and progression a modification of the structure and the function of these genes probably take place which are detected molecular-chemically as activated oncogenes [2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Garrett C (1986) Oncogenes. Clin Chim Acta 156: 1–40

    Article  PubMed  CAS  Google Scholar 

  2. Merkel DE, McGuire WL (1988) Oncogenes and cancer prognosis. In: Devita VT Jr, Hellmann S, Rosenberg eds: Important advances in oncology. Philadelphia: Lippincott JB, pp 103–117

    Google Scholar 

  3. Downward J, Yarden Y, Mayes E, Scrace G, Totty N et al (1984) Close similarity of epidermal growth factor receptor and v-erb B oncogene protein sequences.Nature 307: 521–527

    Article  PubMed  CAS  Google Scholar 

  4. Carpenter G and Cohen S (1979) Epidermal growth factor. Ann Rev Biochem 48: 193–216

    Article  PubMed  CAS  Google Scholar 

  5. Massaque J (1983) Epidermal growth factor like transforming growth factor. J Biol Chem 258: 13606–13614

    Google Scholar 

  6. Derynck R (1986) Transforming growth factor structure and biological activities. J Cell Biochem 32: 293–304

    Article  PubMed  CAS  Google Scholar 

  7. Sainsbury J, Farndorn J, Needham G, Malcolm A, and Harris A (1987) Epidermal growth factor receptor status as predictor for early recurrence of and death from breast cancer. Lancet I: 1398–1402

    Google Scholar 

  8. Bauknecht T, Runge M, Schwall M, and Pfleiderer A (1988) Occurrence of epidermal growth factor receptor in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. Gynecol Oncol 29:147–159

    Article  PubMed  CAS  Google Scholar 

  9. Bauknecht T, Janz I, Kohler M, and Pfleiderer A (1989) Human ovarian carcinomas: Correlation of malignancy and survival with the expression of epidermal growth factor receptor and EGF like factor. Med Oncol Pharmacother 6: 121–127

    CAS  Google Scholar 

  10. Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T (1989) The expression of epidermal growth factor receptor, EGF like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res 9: 1537–1548

    PubMed  CAS  Google Scholar 

  11. Hunts I, Ueda M, Ozawa S, Abe O, Pastan I and Shimizu N (1985) Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. Jpn. J. Cancer Res 76: 663–666

    PubMed  CAS  Google Scholar 

  12. Yasui M, Sumgoski H, Hata I, Kameda I, Ochiai A, Ito H, and Tahara E (1988) Expression of epidermal growth factor receptor in human gastric and colonic carcinoma. Cancer Res 48: 137–141

    PubMed  CAS  Google Scholar 

  13. Keski-Oja J, Leof E, Lyons R, Coffey R, Moses H (1987) Transforming growth factors and control of neoplastic cell growth. J Cell Biochem 33: 95–107

    Article  PubMed  CAS  Google Scholar 

  14. Kistner RW (1979) Adenocarcinoma. In: Gynecologic Principles and Practise, Chicago: Year Book Medical Publisher, Inc., pp 255–272

    Google Scholar 

  15. Aalders JG, Abeler V, and Kolstad P (1984) Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients. Gynecol Oncol 17: 64–74

    Article  PubMed  CAS  Google Scholar 

  16. Chambers SK, Kapp DS, Peschel RE, Lawrence R, Mernio M, Kohoru EI, Schwarz PE (1987) Prognostic factors and sites of failure in Figo stage I, grade 3 endometrial cancer. Gynocol Oncol 27: 180–188

    Article  CAS  Google Scholar 

  17. Grisgby PW, Perez CA, Kushe RR, Kao MS, and Galakatos AE (1987) Results of therapy, analysis of failures and prognostic factors for clinical and pathological stage III adenocarcinoma of the endometrium. Gynocol Oncol 27: 44–57

    Article  Google Scholar 

  18. Goff BA, and Rice LW (1990) Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 38: 46–48

    Article  PubMed  CAS  Google Scholar 

  19. Kleine W, Maier T, Geyer H, and Pfleiderer A (1990) Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance. Gynecol Oncol 38: 59–65

    Article  PubMed  CAS  Google Scholar 

  20. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R (1982) Uterine papillary serous carcinoma: A highly malignant form of endometrial carcinoma. Am J Surg Pathol 6: 93–108

    Article  PubMed  CAS  Google Scholar 

  21. Sutton GP, Brill L, Michael H, Stehmann FB, Ehrlich CE (1987) Malignant papillary lesions of the endometrium. Gynecol Oncol 27: 294–304

    Article  PubMed  CAS  Google Scholar 

  22. Sorbe B, Risberg B, and Frankendal B (1990) DNA ploidy, morphometry and nuclear grade as prognostic factors in endometrial carcinoma. Gynecol Oncol 38: 22–27

    Article  PubMed  CAS  Google Scholar 

  23. Friedlander M, Hedley DW, Taylor I (1984) Clinical and biological significance of aneuploidy in human tumors. J. Clin. Pathol. 37: 961–974

    CAS  Google Scholar 

  24. TSOU KC, Hong DH, Varello MA et al. (1985) Flow cytometric DNA and 5’nucleotide phosphodiesterase in endometrium. Cancer 56: 2340–2347

    Article  Google Scholar 

  25. Sasano H, Comeford J, Wilkinson D, Schwartz A, Garrett C (1990) Serous papillary adenocarcinoma of the endometrium: Analysis of proto-oncogene amplification, flow cytometry, estrogen and progesterone receptors, and immunohistochemistry. Cancer 65: 1545–1551

    Article  PubMed  CAS  Google Scholar 

  26. Bauknecht T, Rau B, Meerpohl HG, Pfleiderer A (1984) The prognostic value of the presence of epidermal growth factor receptor in ovarian carcinomas. Tumor Diagnostik Therapie 5: 62–66

    Google Scholar 

  27. Wittmaack FM, Schwörer D, Wintzer HO, von Kleist S, Pfleiderer A, Bauknecht T (1988) The immunohistochemical investigation of epidermal growth factor receptor in various gynecological tumors. IJIPP 1: 139–147

    Google Scholar 

  28. Bauknecht T, Kohler M, Janz I, Pfleiderer A (1989) The occurrence of epidermal growth factor receptor and the characterisation of EGF like factors in human ovarian, endometrial, cervical and breast cancer. J Cancer Res Clin Oncol 115: 193–199

    Article  PubMed  CAS  Google Scholar 

  29. Bauknecht T, Gross G, Hagedorn M (1985) Epidermal growth factor receptor in different skin tumors. Dermatologica 171: 16–20

    Article  PubMed  CAS  Google Scholar 

  30. Veale D, Marsh C, Ashcroft T, Harris A (1985) Epidermal growth factor receptor in non-small cell lung cancer. Br J Cancer 52: 441

    Google Scholar 

Download references

Authors
  1. Thomas Bauknecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Frauenklinik, Hugstetter Straße 55, W-7800, Freiburg, Deutschland

    Werner Kleine , Hans-Gerd Meerpohl  & Albrecht Pfleiderer ,  & 

  2. Farmitalia Carlo Erba GmbH, Merzhauser Straße 112, W-7800, Freiburg, Deutschland

    Christian Z. Profous

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bauknecht, T. (1991). EGF Receptor (EGF-R) Analysis in Endometrial Carcinomas. In: Kleine, W., Meerpohl, HG., Pfleiderer, A., Profous, C.Z. (eds) Therapie des Endometriumkarzinoms. AGO Arbeitsgemeinschaft für Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76950-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76950-4_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54571-2

  • Online ISBN: 978-3-642-76950-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation